Loading clinical trials...
Loading clinical trials...
This study will investigate the effect on ambulatory blood pressure of lumiracoxib 100 mg once daily versus ibuprofen 600 mg three times a day in osteoarthritis patients with controlled hypertension.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT07217405 · Osteoarthritis Hand, Osteoarthritis Wrist
NCT07551245 · Knee Arthritis Osteoarthritis
NCT06755697 · Knee Osteoarthritis, Glucose, and more
NCT06702046 · Osteoarthritis (OA) of the Knee
NCT05986292 · Osteoarthritis, Knee, Diabetic Neuropathic Pain, and more
Southern Illinois Clinical Research
O'Fallon, Illinois
Novartis
Nuremberg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions